+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market Research Reports

Global Obesity Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Obesity Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
Growth Opportunities in Respiratory and Neurological Disease Management, RNA Therapeutics, and Drugs for Obesity and Rare Diseases - Product Thumbnail Image

Growth Opportunities in Respiratory and Neurological Disease Management, RNA Therapeutics, and Drugs for Obesity and Rare Diseases

  • Report
  • July 2021
  • 35 Pages
  • Global
Fat Reduction Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Fat Reduction Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • October 2023
  • 150 Pages
  • Global
From
Investigation Report on China's Liraglutide Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Liraglutide Market 2021-2025

  • Report
  • June 2021
  • 50 Pages
  • China
From
South & Central America Noninvasive Fat Reduction Market Forecast to 2031 - Regional Analysis - by Technology and End User - Product Thumbnail Image

South & Central America Noninvasive Fat Reduction Market Forecast to 2031 - Regional Analysis - by Technology and End User

  • Report
  • October 2024
  • 58 Pages
From
Anti-obesity Drug Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Anti-obesity Drug Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 140 Pages
  • Global
From
Anti-Obesity Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Anti-Obesity Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 137 Pages
  • Global
From
WEGOVY Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

WEGOVY Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
XENICAL (Orlistat), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

XENICAL (Orlistat), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
WEGOVY (Semaglutide), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

WEGOVY (Semaglutide), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
CONTRAVE (Naltrexon-Bupropion), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

CONTRAVE (Naltrexon-Bupropion), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
QSYMIA (Phentermine-Topiramate), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

QSYMIA (Phentermine-Topiramate), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
IMCIVREE (Setmelanotide), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

IMCIVREE (Setmelanotide), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Non-Invasive Fat Reduction Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Non-Invasive Fat Reduction Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 113 Pages
  • Global
From
Hypothalamic Obesity - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Hypothalamic Obesity - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
HET Obesity/POMC Deficiency Obesity - Epidemiology Forecast to 2032 - Product Thumbnail Image

HET Obesity/POMC Deficiency Obesity - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hypothalamic Obesity - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hypothalamic Obesity - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
South Korea Body Fat Reduction Market Report and Forecast 2024-2032 - Product Thumbnail Image

South Korea Body Fat Reduction Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 160 Pages
  • South Korea
From
Anti-Obesity Drugs Market Analysis & Forecast 2024-2034: Market By Drug; By Mechanism Of Action; By Route Of Administration; By Distribution Channel; and By Region - Product Thumbnail Image

Anti-Obesity Drugs Market Analysis & Forecast 2024-2034: Market By Drug; By Mechanism Of Action; By Route Of Administration; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Loading Indicator

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat. The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more